 In representing Purdue Pharma, maker of OxyContin, in a case against the Drug Enforcement Administration, Giuliani Partners negotiated a $2 million fine and no further penalty for what the DEA called "lax security" at plants that produced the drug, which the DEA said was being used as a recreational drug.The lead DEA investigator later said that Purdue Pharma escaped harsher penalties in the case because of Giuliani's connections to government officials.Giuliani later represented Purdue Pharma in a recently settled case in which the DEA accused the company of marketing OxyContin by playing down its level of addictive properties.